EMA — authorised 21 March 2018
- Marketing authorisation holder: Argenx
- Status: approved
🇪🇺 Vyvgart in European Union
EMA authorised Vyvgart on 21 March 2018
Marketing authorisation
Vyvgart in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Vyvgart approved in European Union?
Yes. EMA authorised it on 21 March 2018.
Who is the marketing authorisation holder for Vyvgart in European Union?
Argenx holds the EU marketing authorisation.